EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Inactivation Validation of Ebola, Marburg, and Lassa Viruses in AVL and Ethanol-Treated Viral Cultures

Todd Cutts iD, Anders Leung, Logan Banadyga iD, Jay Krishnan

Viruses · 2024

DOI: 10.3390/v16091354 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Viruses, 2024. Verfasst von Todd Cutts und 3 weiteren Autor:innen. Beteiligte Einrichtung: National Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, MB R3E 3R2, Canada. Hauptthemen laut MEDLINE: Lassa virus, Marburgvirus, Ebolavirus, Ethanol. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Public Health Agency of Canada.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

High-consequence pathogens such as the Ebola, Marburg, and Lassa viruses are handled in maximum-containment biosafety level 4 (BSL-4) laboratories. Genetic material is often isolated from such viruses and subsequently removed from BSL-4 laboratories for a multitude of downstream analyses using readily accessible technologies and equipment available at lower-biosafety level laboratories. However, it is essential to ensure that these materials are free of viable viruses before removal from BSL-4 laboratories to guarantee sample safety. This study details the in-house procedure used for validating the inactivation of Ebola, Marburg, and Lassa virus cultures after incubation with AVL lysis buffer (Qiagen) and ethanol. This study’s findings show that no viable virus was detectable when high-titer cultures of Ebola, Marburg, and Lassa viruses were incubated with AVL lysis buffer for 10 min, followed by an equal volume of 95% ethanol for 3 min, using a method with a sensitivity of ≤0.8 log10 TCID50 as the limit of detection.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Lassa virusMarburgvirusEbolavirusEthanolVirus InactivationAnimalsHumansContainment of BiohazardsLassa FeverVirus CultivationChlorocebus aethiopsVero Cells

Stichwörter der Autor:innen

AVLBSL-4Ebola virusLassa virusMarburg virusRG4 viral familiesinactivation validationlysis buffervirus inactivation

Substanzen

Ethanol

Autor:innen und Institutionen

  • National Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, MB R3E 3R2, Canada.
  • Department of Medical Microbiology and Infectious Diseases, University of Manitoba, Winnipeg, MB R3E 0J9, Canada.

ORCID-Profile: Todd Cutts, Logan Banadyga

Förderung

  • Public Health Agency of Canada

Zitieren

APA

Cutts, T., Leung, A., Banadyga, L., & Krishnan, J. (2024). Inactivation Validation of Ebola, Marburg, and Lassa Viruses in AVL and Ethanol-Treated Viral Cultures. Viruses. https://doi.org/10.3390/v16091354

Vancouver

Cutts T, Leung A, Banadyga L, Krishnan J. Inactivation Validation of Ebola, Marburg, and Lassa Viruses in AVL and Ethanol-Treated Viral Cultures. Viruses. 2024. doi:10.3390/v16091354

BibTeX
@article{Cutts2024,
  author = {Cutts, Todd and Leung, Anders and Banadyga, Logan and Krishnan, Jay},
  title = {Inactivation Validation of Ebola, Marburg, and Lassa Viruses in AVL and Ethanol-Treated Viral Cultures},
  journal = {Viruses},
  year = {2024},
  doi = {10.3390/v16091354}
}
Kostenlos starten →